Accepted for Publication: March 5, 2015.
Published Online: June 3, 2015. doi:10.1001/jamadermatol.2015.0739.
Study concept and design: Olsen, Whiteman.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Olsen, Thompson, Green.
Critical revision of the manuscript for important intellectual content: Olsen, Green, Neale, Whiteman.
Statistical analysis: Olsen, Whiteman.
Obtained funding: Green, Whiteman.
Administrative, technical, or material support: Olsen, Thompson, Whiteman.
Study supervision: Whiteman.
Conflict of Interest Disclosures: None reported.
Funding/Support: This study was supported by program grant 552429 from the National Health and Medical Research Council of Australia (Drs Green and Whiteman). Drs Neale and Whiteman are supported by research fellowships from the National Health and Medical Research Council of Australia.
Role of the Funder/Sponsor: The funding source had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and the decision to submit the manuscript for publication.
Additional Contributions: We are indebted to Melanoma Patients Australia for their support and assistance and to the Queenslanders who have willingly given their time to take part in the QSkin Sun and Health Study.
Group Information: The members of the QSkin Sun and Health Study are as follows: chief investigators: David C. Whiteman, MBBS, PhD, Catherine M. Olsen, PhD, Adèle C. Green, MBBS, PhD; associate investigators: Rachel E. Neale, PhD, Penelope M. Webb, PhD; study team: Rebekah A. Cicero, BA, Lea M. Jackman, Dip BA, Suzanne M. O’Brien, MPH, Barbara A. Ranieri, Bridie S. Thompson, PhD; clinical collaborators: Conrad J. Morze, MBBS, H. Peter Soyer, MD; scientific advisory board: Dallas English, MD, and Allison Venn, PhD.